Roivant Sciences

• Sep 18Held a shareholder voteOfficial announcement, SEC filing (8-K)
• Sep 8Shared news with investorsOfficial announcement, SEC filing (8-K)
• Aug 28Shared other company newsOfficial announcement, SEC filing (8-K)
• Aug 27Shared news with investorsOfficial announcement, SEC filing (8-K)

• Sep 8Roivant Sciences' Pulmovant Reports Positive Phase 2 Results for Mosliciguat in PH-ILDMT Newswires

Headlines link to the original article. Lists and “should you buy” pieces are left out. Coverage is not a recommendation.